Epigenomics AG announces changes in its Executive Management Board
The Supervisory Board of Epigenomics AG and its current CEO Geert Walter Nygaard agreed that Mr. Nygaard will leave the Executive Management Board of the company effective 30 September 2012.
The current CFO, Dr. Thomas Taapken, thereby becomes the sole Executive Board member of the company and this capacity also takes over the responsibility of acting CEO of Epigenomics, effective 1 October 2012. Dr. Uwe Staub, currently SVP R&D was promoted to COO and was granted “Prokura” (power of attorney). His duties will be expanded by the responsibility for medical affairs and customer support.
Most read news
Organizations
Other news from the department people
Get the life science industry in your inbox
By submitting this form you agree that LUMITOS AG will send you the newsletter(s) selected above by email. Your data will not be passed on to third parties. Your data will be stored and processed in accordance with our data protection regulations. LUMITOS may contact you by email for the purpose of advertising or market and opinion surveys. You can revoke your consent at any time without giving reasons to LUMITOS AG, Ernst-Augustin-Str. 2, 12489 Berlin, Germany or by e-mail at revoke@lumitos.com with effect for the future. In addition, each email contains a link to unsubscribe from the corresponding newsletter.